The historical rank and industry rank for Parenteral Drugs (India)'s Days Inventory or its related term are showing as below:
NSE:PDPL's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.43 * Ranked among companies with meaningful Days Inventory only.
Parenteral Drugs (India)'s Days Inventory
declined
from Mar. 2021 (114.60) to Mar. 2022 (53.34).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Parenteral Drugs (India)'s Inventory Turnover for the
three
months ended in Mar. 2022 was 1.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Parenteral Drugs (India)'s Inventory-to-Revenue for the
three
months ended in Mar. 2022 was 0.58.
Parenteral Drugs (India) (NSE:PDPL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Parenteral Drugs (India)'s Inventory Turnover for the
three
months ended in Mar. 2022 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Parenteral Drugs (India)'s Inventory to Revenue for the
three
months ended in Mar. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Parenteral Drugs (India) Days Inventory Related Terms
Parenteral Drugs (India) Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PDPL vs ZTS, CTLT, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Parenteral Drugs (India) Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Days Inventory distribution charts can be found below:
* The bar in red indicates where Parenteral Drugs (India)'s Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Parenteral Drugs (India) (NSE:PDPL) has a Days Inventory of 53.34 as of Mar. 2022. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s Days Inventory too high?
Parenteral Drugs (India)'s current Days Inventory is 53.34. The Drug Manufacturers industry median Days Inventory is 164.43. Parenteral Drugs (India)'s value of 53.34 is 67.6% below this industry median. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s Days Inventory compare to ZTS and CTLT?
Parenteral Drugs (India)'s Days Inventory of 53.34 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.43. Parenteral Drugs (India)'s value of 53.34 is 67.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Parenteral Drugs (India)'s current Days Inventory of 53.34 is 67.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Parenteral Drugs (India) and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Parenteral Drugs (India)'s current Days Inventory is 53.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current Days Inventory of 53.34. The current Days Inventory is 53.34 and 67.6% below the Drug Manufacturers industry median of 164.43. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current Days Inventory is 53.34 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score
Get the complete analysis for NSE:PDPL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PDPL has been successfully added to your 
